SCHEMBL5879172

SCHEMBL5879172

COc1cc(OCCCC(N)=O)ccc1C=O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.58
MAOB P27338 2/20 0.54
S1PR1 P21453 1/20 0.47
PDE3B Q13370 1/20 0.45
PDE3A Q14432 1/20 0.45
P2RY12 Q9H244 1/20 0.45
MEN1 O00255 1/20 0.44
MAPT P10636 1/20 0.44
KMT2A Q03164 1/20 0.44
ERN1 O75460 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.43
CYP1A1 P04798 1/20 0.43
CYP1B1 Q16678 1/20 0.43
ROCK2 O75116 1/20 0.43
ROCK1 Q13464 1/20 0.43
HDAC8 Q9BY41 2/20 0.43
TUBB1 Q9H4B7 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1124419 0.89 ALDH1A1 (0.58) ALDH1A1MAOBS1PR1PDE3BPDE3A
SCHEMBL2160315 0.88 ALDH1A1 (0.54) ALDH1A1MAOBS1PR1MEN1MAPT
SCHEMBL2160313 0.88 ALDH1A1 (0.54) ALDH1A1MAOBS1PR1MEN1MAPT
SCHEMBL2562580 0.86 ALDH1A1 (0.61) ALDH1A1MAOBMEN1MAPTKMT2A
SCHEMBL4529316 0.85 ALDH1A1 (0.54) ALDH1A1MAOBS1PR1PDE3BPDE3A
SCHEMBL2654870 0.84 PTPN1 (0.55) ALDH1A1MAOBPDE3BPDE3AP2RY12
SCHEMBL4529312 0.84 ALDH1A1 (0.52) ALDH1A1MAOBS1PR1MEN1MAPT
SCHEMBL4059477 0.84 ALDH1A1 (0.67) ALDH1A1MAOBERN1CYP1A2L3MBTL1
SCHEMBL2556331 0.83 ALDH1A1 (0.58) ALDH1A1MEN1MAPTKMT2AERN1
SCHEMBL12744692 0.83 ALDH1A1 (0.51) ALDH1A1MAOBS1PR1MAPTERN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7034056-B2 Aryl and biaryl compounds having MCH modulatory activity PHARMACOPEIA DRUG DISCOVERY, INC. (US) 2006-04-25 US disclosed
EP-1370520-A1 ARYL AND BIARYL COMPOUNDS HAVING MCH MODULATORY ACTIVITY PHARMACOPEIA, INC. (US) 2003-12-17 EP disclosed
US-20030092715-A1 Aryl and biaryl compounds having MCH modulatory activity SCHERING CORPORATION 2003-05-15 US disclosed
WO-2002076929-A1 ARYL AND BIARYL COMPOUNDS HAVING MCH MODULATORY ACTIVITY PHARMACOPEIA, INC. (US) 2002-10-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030092715-A1 Aryl and biaryl compounds having MCH modulatory activity MCHR1, MCHR2, MC3R ALDH1A1 1069/4885MAOB 313/4885S1PR1 289/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.